CRISPR screening of SCLC cell lines revealed that POU class 2 homeobox 3 (POU2F3), a powerful TF, was expressed exclusively and necessary in the variant subtype of SCLC lacking NE marker expression [46]. This evidence concerns the gene POU3F2 and small cell lung carcinoma.